Everything below concerns GLP-1 receptor. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-09-24. Where a claim depends on a specific study, the study is described rather than over-claimed.
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1 (GLP-1), a hormone released from intestinal L-cells after food intake. The compound belongs to the incretin mimetic class and acts at GLP-1 receptors distributed across pancreatic, gastrointestinal, cardiovascular, and central nervous system tissues. Compared with native GLP-1, the molecule carries structural changes that extend its activity from minutes to roughly one week. It is studied for glycemic control in type 2 diabetes and for weight management, and its effects on cardiovascular and other outcomes remain active research areas.
Receptor binding triggers G protein signaling that raises intracellular cyclic AMP in pancreatic beta cells. Insulin release follows in a glucose-dependent manner, so secretion increases when blood glucose is elevated and diminishes when it is not. The same signaling suppresses glucagon release from alpha cells and slows gastric emptying, which blunts the post-meal glucose rise. In the brain, receptor activation in regions such as the arcuate nucleus is associated with reduced appetite and lower energy intake. How much each of these effects contributes to overall weight change is not fully settled.
The primary target is the GLP-1 receptor, a class B G protein-coupled receptor expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises intracellular cyclic AMP, which potentiates glucose-dependent insulin secretion and lowers glucagon release when blood glucose is elevated. Signalling in the hypothalamus and brainstem is associated with reduced appetite and slower gastric emptying. Because the insulinotropic effect depends on prevailing glucose levels, the hypoglycaemic risk of the peptide alone is described as low in most study settings. The relative contribution of peripheral and central actions remains an active research question.
Large randomised trials in adults with type 2 diabetes and in adults with obesity have reported reductions in body weight and improvements in several cardiovascular risk markers. One outcome trial found a lower incidence of major adverse cardiovascular events in participants with diabetes and established cardiovascular disease. Gastrointestinal effects such as nausea and vomiting are the most frequently reported adverse events and often diminish over time. Changes in lean body mass during weight loss are an area of ongoing investigation. Effects in adolescents and in pregnancy are less well characterised, and current labelling advises against use during pregnancy.
| Property | Value | Notes |
|---|---|---|
| Chemical class | GLP-1 receptor agonist peptide | Mimics endogenous incretin signaling |
| Molecular mass | Approximately 4114 Da | Modified 31-amino-acid backbone |
| Appearance | White to off-white powder | Typical of lyophilized peptide material |
| Solubility | Soluble in water | Behavior depends on salt form and buffer |
| Elimination half-life | About one week | Supported by albumin binding and protease resistance |
Lyophilized semaglutide powder is typically held at minus twenty degrees Celsius for long-term storage. At that temperature, solid-state degradation reactions proceed slowly and the peptide remains intact for extended periods. Repeated freeze-thaw cycles are best avoided because they promote aggregation and can shift the proportion of monomeric peptide present. Working aliquots are often prepared so that each portion is thawed only once, and desiccant is placed inside the vial to limit moisture uptake.
Identity and purity are usually assessed by reverse-phase high-performance liquid chromatography coupled to mass spectrometry. Retention time and observed mass are compared against a reference standard run under identical conditions. Impurity profiles reveal deamidation products, oxidized methionine variants, and truncated fragments that arise during synthesis or storage. Peptide mapping through enzymatic digestion confirms the primary sequence, while amino acid analysis offers an independent check on overall composition.
Stability studies examine how temperature, pH, and moisture influence degradation rates over time. In aqueous solution, hydrolysis and deamidation accelerate as pH moves away from mildly acidic conditions. Light exposure and residual metal ions can also trigger oxidation of susceptible residues. Accelerated aging at elevated temperature is used to estimate shelf life, though extrapolation to room temperature carries uncertainty because individual degradation pathways do not always scale predictably.
Semaglutide is a synthetic peptide that acts as an agonist at the glucagon-like peptide-1 receptor. It is a structural analogue of human GLP-1(7-37), modified to resist enzymatic degradation by dipeptidyl peptidase-4. The peptide backbone contains alpha-aminoisobutyric acid at position 8, a substitution that stabilises the helix and slows cleavage. A fatty diacid side chain attached through a linker at lysine 34 promotes binding to serum albumin, which extends the circulating half-life. These two modifications together allow less frequent administration than native GLP-1 requires.
Activation of the GLP-1 receptor couples to Gs signalling and raises intracellular cyclic AMP in pancreatic beta cells. The resulting insulin release depends on prevailing glucose concentrations, so the effect is greater when glucose is elevated. Receptor engagement also suppresses glucagon secretion and slows gastric emptying, which flattens post-meal glucose excursions. In the central nervous system, signalling in hypothalamic and brainstem regions is associated with reduced appetite and lower energy intake. Studies continue to examine effects on cardiac, renal and hepatic endpoints; whether those benefits are independent of weight change remains an open question.
Clinical development of this compound followed earlier short-acting GLP-1 analogues that required frequent injection. Once-weekly subcutaneous formulations entered use after 2017, and an oral formulation using a permeation enhancer later became available. The oral version pairs the peptide with sodium N-(8-[2-hydroxybenzoyl] amino) caprylate, a carrier that improves uptake across the gastric epithelium. Interest has expanded from glycaemic control into weight management and metabolic liver disease. Regulatory status and approved indications differ between countries, and the product remains subject to ongoing safety monitoring.
In pharmacology, bioavailability is a subcategory of absorption and is the fraction (%) of an administered drug that reaches the systemic circulation. By definition, when a medication is administered intravenously, its bioavailability is 100%. However, when a medication is administered via routes other than intravenous, its bioavailability is lower due to intestinal epithelium absorption and first-pass metabolism. Thereby, mathematically, bioavailability equals the ratio of comparing the area under the plasma drug concentration curve versus time (AUC) for the extravascular formulation to the AUC for the intravascular formulation. AUC is used because AUC is proportional to the dose that has entered the systemic circulation. Bioavailability of a drug is an average value; to take population variability into account, deviation range is shown as ±. To ensure that the drug taker who has poor absorption is dosed appropriately, the bottom value of the deviation range is employed to represent real bioavailability and to calculate the drug dose needed for the drug taker to achieve systemic concentrations similar to the intravenous formulation. To dose without knowing the drug taker's absorption rate, the bottom value of the deviation range is used in order to ensure the intended efficacy, unless the drug is associated with a narrow therapeutic window. For dietary supplements, herbs and other nutrients in which the route of administration is nearly always oral, bioavailability generally designates simply the quantity or fraction of the ingested dose that is absorbed.
Artocarpus lacucha, also known as monkey jack or monkey fruit, is a tropical evergreen tree species of the family Moraceae. It is distributed throughout the Indian subcontinent and Southeast Asia. The tree is valued for its wood; its fruit is edible and is believed to have medicinal value. In Northeastern Thailand, the wood is used to make pong lang, a local traditional instrument. This tree is mentioned in the Arthashastra.
According to the CIA and the Central Bank of Somalia, with ongoing civil unrest, the Somali economy is primarily limited to livestock and remittance/money transfers from Somalis living in more economically advanced countries, and local telecommunications. Owing to a dearth of formal government statistics and ongoing decades-long iterations of civil war, it is difficult to gauge the size or growth of the economy. For 1994, the CIA estimated the GDP at US$3.3 billion. In 2001, it was estimated to be US$4.1 billion. By 2009, the CIA estimated that the GDP had grown to US$5.731 billion, with a projected real growth rate of 2.6%. According to a 2007 British Chambers of Commerce report, during a period of relatively less internal warfare, the private sector had also grown, particularly in the service sector. Unlike the pre-civil war period, when most services and the industrial sector were government-run, the 2007 report noted substantial, albeit unmeasured, private investment in commercial activities; this has been largely financed by the Somali diaspora, and included trade and marketing, money transfer services, transportation, communications, fishery equipment, airlines, telecommunications, education, health, construction and hotels. In 2007, Libertarian economist Peter Leeson attributed this increased economic activity to the Somali customary law (referred to as Xeer), which he suggests provides a stable environment to conduct business in. According to the Central Bank of Somalia, the country's GDP per capita as of 2012 was US$226, a slight reduction in real terms from 1990.
=== Etymology === The English word is from Classical Nahuatl chīlli with the same meaning. The name of the plant is unrelated to that of the country Chile. While pepper originally meant the genus Piper, not Capsicum, the Oxford English Dictionary and Merriam-Webster record both usages. The three primary spellings are chili (common in North America), chile (Central America and parts of the US) and chilli (United Kingdom and former British colonies). The specific dish name "chili con carne" is normally written with one "l" in both American and British English.
Sources: en.wikipedia.org
Analyses on model and non-model eukaryotic proteomes have revealed that LCRs are frequently found in proteins involved in binding of nucleic acids (DNA or RNA), in transcription, receptor activity, development, reproduction and immunity whereas metabolic proteins are depleted of LCRs. A bioinformatics study of the UniProt annotation of LCR containing proteins observed that 44% (9751/22259) of Bacterial and 44% (662/1521) of Archaeal LCRs are detected in proteins of unknown function, however, a significant number of proteins of known function (from many different species), especially those involved in translation and the ribosome, nucleic acid binding, metal-ion binding, and protein folding were also found to contain LCRs.
On September 15, 2012, David Wood, Deputy Director of the EBU Technology and Development Department (who chairs the ITU working group that created Rec. 2020), told The Hollywood Reporter that South Korea plans to begin test broadcasts of 4K UHDTV next year. Wood also said that many broadcasters have the opinion that going from HDTV to 8K UHDTV is too much of a leap and that it would be better to start with 4K UHDTV. In the same article, Masakazu Iwaki, NHK Research senior manager, said that the NHK plan to go with 8K UHDTV is for economic reasons since directly going to 8K UHDTV would avoid an additional transition from 4K UHDTV to 8K UHDTV. On October 18, 2012, the Consumer Electronics Association (CEA) announced that it had been unanimously agreed by the CEA's Board of Industry Leaders that the term "Ultra High-Definition", or "Ultra HD", would be used for displays that have a resolution of at least 8 megapixels with a vertical resolution of at least 2,160 pixels and a horizontal resolution of at least 3,840 pixels. The Ultra HD label also requires the display to have an aspect ratio of 16:9 or wider and to have at least one digital input that can carry and present a native video signal of 3840 × 2160 without having to rely on a video scaler. Sony announced they would market their 4K products as 4K Ultra High-Definition (4K UHD). On October 23, 2012, Ortus Technology Co., Ltd announced the development of the world's smallest 3840 × 2160 pixel LCD panel with a size of 9.6 inches (24 cm) and a pixel density of 458 px/in.
== Further reading == Lin, Y.; Zou, J.; Yang, W.; Li, C. Q. (2018). "A Review of Recent Advances in Research on PM2.5 in China". International Journal of Environmental Research and Public Health. 15 (3): 438. Bibcode:2018IJERP..15..438L. doi:10.3390/ijerph15030438. PMC 5876983. PMID 29498704. Abdel Hameed, A. A.; Yasser, I. H.; Khoder, I. M. (2004). "Indoor air quality during renovation actions: a case study". Journal of Environmental Monitoring. 6 (9): 740–744. Bibcode:2004JEnMo...6..740A. doi:10.1039/b402995j. PMID 15346177.
Sources: en.wikipedia.org
Native GLP-1 is degraded within minutes by dipeptidyl peptidase-4 and cleared quickly. Semaglutide carries a position 8 substitution that blocks that cleavage and a fatty diacid chain that binds albumin. Together these changes extend its circulating half-life to about one week.
Yes. Stimulation of insulin secretion is glucose-dependent, meaning the effect is larger when blood glucose is high and minimal when it is normal. This property separates GLP-1 receptor agonists from agents that drive insulin release regardless of glucose level.
Receptor expression in hypothalamic and brainstem regions is well documented, and reduced energy intake is consistently observed. The relative contribution of central versus peripheral signaling to total weight change is still an open question addressed by ongoing research.
Native GLP-1 is degraded within minutes by dipeptidyl peptidase-4 and neutral endopeptidases. Semaglutide carries a non-natural amino acid at position eight that blocks that cleavage, and a fatty diacid side chain that binds albumin. The result is a much longer duration of action than the native hormone.